SCHEMBL1444685

SCHEMBL1444685

NC1(CO)CCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24478146 1.00
Hydrochloric Acid SCHEMBL1185503 0.98
SCHEMBL1444636 0.86
SCHEMBL1350960 0.84
SCHEMBL12171586 0.78
SCHEMBL30060324 0.77
SCHEMBL16846706 0.77
SCHEMBL21505987 0.76 ALDH1A1 (0.30)
SCHEMBL15984794 0.75
SCHEMBL14852716 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119490451-A Compounds as positive modulators of calcium activated chloride channels TMEM16A有限公司 2025-02-21 CN disclosed
CN-116234550-B Aromatic formyl substituted tricyclic compound and preparation method and application thereof 劲方医药科技(上海)股份有限公司 2024-12-27 CN disclosed
CN-111683926-B Compounds of formula (I) 企业治疗学有限公司 2024-11-08 CN disclosed
WO-2023154344-A1 2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-08-17 WO disclosed
EP-4223753-A1 AROYL SUBSTITUTED TRICYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Genfleet Therapeutics (Shanghai) Inc. (CN) 2023-08-09 EP disclosed
CN-116234550-A Aromatic formyl substituted tricyclic compound and preparation method and application thereof 劲方医药科技(上海)有限公司 2023-06-06 CN disclosed
US-20230014907-A1 INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED 2023-01-19 US disclosed
WO-2022063101-A1 AROYL SUBSTITUTED TRICYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 劲方医药科技(上海)有限公司 2022-03-31 WO disclosed
WO-2021252849-A1 INHIBITORS OF APOL1 AND USE OF THE SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2021-12-16 WO disclosed
CN-109641875-B Diacylglycerol acyltransferase 2 inhibitors 辉瑞公司 2021-08-31 CN disclosed
US-8901112-B2 Spirocyclic aminoquinolones as GSK-3 inhibitors KYORIN PHARMACEUTICAL CO., LTD. (JP) 2014-12-02 US disclosed
US-8476261-B2 Spirocyclic aminoquinolones as GSK-3 inhibitors KYORIN PHARMACEUTICAL CO., LTD. (JP) 2013-07-02 US disclosed
US-8476261-B2 Spirocyclic aminoquinolones as GSK-3 inhibitors KYORIN PHARMACEUTICAL CO., LTD. (JP) 2013-07-02 US disclosed
US-8328882-B2 Gentle dyeing and lightening agents having improved lightening power HENKEL AG & CO. KGAA (DE) 2012-12-11 US disclosed
EP-2477701-A2 GENTLE DYEING AND LIGHTENING AGENTS HAVING IMPROVED LIGHTENING POWER Henkel AG & Co. KGaA (DE) 2012-07-25 EP disclosed
US-20120171135-A1 Gentle Dyeing and Lightening Agents Having Improved Lightening Power HENKEL AG & CO. KGAA (DE) 2012-07-05 US disclosed
WO-2011032762-A2 GENTLE DYEING AND LIGHTENING AGENTS HAVING IMPROVED LIGHTENING POWER HENKEL AG & CO. KGAA (DE) 2011-03-24 WO disclosed
US-20110034436-A1 SPIROCYCLIC AMINOQUINOLNES AS GSK-3 INHIBITORS KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-02-10 US disclosed
US-20110034436-A1 SPIROCYCLIC AMINOQUINOLNES AS GSK-3 INHIBITORS KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-02-10 US disclosed
WO-2009035684-A1 SPIROCYCLIC AMINOQUINOLONES AS GSK-3 INHIBITORS ACTIVX BIOSCIENCES, INC. (US) 2009-03-19 WO disclosed